CrushSCI.com
43.6Average days
48Median days
27Fastest days
48Longest days
632025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

27 days

Integrative Cross-platform Analysis of Kinase Inhibitor Effects on Statin-relevant Cardioprotective Pathways in Human Cardiomyocytes

Authors
TAI-YU KUO; MIN-CHI CHENG; HONG-JIE JHOU; CHO-HAO LEE; PO-HUANG CHENShow moreShow less
Affiliations
1. Department of Internal Medicine, Taoyuan Armed Forces General Hospital, National Defense Medical University, Taoyuan, Taiwan, R.O.C.; 2. Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, R.O.C.; 3. Department of Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, R.O.C.; 4. Neurological Institute, Changhua Christian Hospital, Changhua, Taiwan, R.O.C.Show moreShow less
Official full-text evidence DOI Publisher page
48 days

Tumor Suppressive Role of Hsa-miR-328-3p in Colon Cancer by Regulating EN2

Authors
YUN JU LEE; DU HYEONG LEE; HYEON-SU JEONG; HYUN-YOUNG ROH; GA-RAM JEONG; HEUI-SOO KIMShow moreShow less
Affiliations
1. Department of Integrated Biological Science, Pusan National University, Busan, Republic of Korea; 2. Institute of Systems Biology, Pusan National University, Busan, Republic of Korea; 3. Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Republic of KoreaShow moreShow less
Official full-text evidence DOI Publisher page
47 days

Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling

Authors
Wen-Hua Chung; Chi-Fen Chang; Chao-Yuan Huang; Chia-Cheng Yu; Victor C. Lin; Te-Ling Lu; Shu-Pin Huang; Bo-Ying BaoShow moreShow less
Affiliations
1. Department of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.; 2. Department of Anatomy, School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.; 3. Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, R.O.C.; 4. Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.; 5. Department of Urology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; 6. Department of Pharmacy, College of Pharmacy and Health Care, Tajen University, Pingtung, Taiwan, R.O.C.; 7. Department of Urology, E-Da Hospital, Kaohsiung, Taiwan, R.O.C.; 8. School of Medicine for International Students, I-Shou University, Kaohsiung, Taiwan, R.O.C.; 9. Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.; 10. Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.; 11. Institute of Medical Science and Technology, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C.Show moreShow less
Official full-text evidence DOI Publisher page
48 days

GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method

Authors
YI-FEI YANG; YUN GENG; HUI XU; KAZUNORI AKIMOTO; YUN-WEN ZHENG; YUYUN XIONG; YU-MEI LIShow moreShow less
Affiliations
1. Institute of Regenerative Medicine, and Department of Dermatology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, P.R. China; 2. Department of Medical and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan; 3. Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan; 4. Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine and South China Institute of Large Animal Models for Biomedicine, Wuyi University, Jiangmen, P.R. China; 5. School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, P.R. China; 6. Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, JapanShow moreShow less
Official full-text evidence DOI Publisher page
48 days

IL1B-Expressing Exhausted CD4+ T Cells Are Associated With Disease Aggressiveness in Glioblastoma

Authors
JINSHAN WANG; AO ZHU; JIAN WANG; BIN HU; KASHIF RAFIQ ZAHID; AILIANG ZENG; YIHENG TAN; JIA YANGShow moreShow less
Affiliations
1. Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China; 2. Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China; 3. Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A.; 4. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.; 5. Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 6. Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, P.R. ChinaShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.